Aigen Investment Management, LP Apellis Pharmaceuticals, Inc. Transaction History

Aigen Investment Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$55.39 - $72.47 $307,968 - $402,933	5,560 New	5,560 $326,000
Q2 2023 Aug 14, 2023	BUY	$76.68 - $93.31 $1.67 Million - $2.04 Million	21,827 New	21,827 $1.99 Million
Q3 2022 Nov 09, 2022	BUY	$44.76 - $69.66 $153,884 - $239,491	3,438 New	3,438 $235,000
Q3 2021 Nov 12, 2021	SELL	$31.4 - $69.84 $160,045 - $355,974	-5,097 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$40.9 - $64.9 $208,467 - $330,795	5,097 New	5,097 $322,000
Q4 2020 Feb 12, 2021	SELL	$30.79 - $57.2 $317,383 - $589,617	-10,308 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$25.89 - $33.65 $266,874 - $346,864	10,308 New	10,308 $311,000
Q2 2020 Aug 10, 2020	SELL	$24.8 - $38.49 $729,417 - $1.13 Million	-29,412 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$17.91 - $44.33 $526,768 - $1.3 Million	29,412 New	29,412 $788,000

301

111M

2.63M

845K

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.67B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.